- Home
- CODX
CODX
Co-Diagnostics Inc.
as 07-26-2024 4:00pm EST
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | SALT LAKE CITY |
| Market Cap: | 33.2M | IPO Year: | 2017 |
| Target Price: | $2.00 | AVG Volume (30 days): | 81.1K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.32 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.98 - $1.73 | Next Earning Date: | 08-08-2024 |
| Revenue: | $6,677,935 | Revenue Growth: | -44.91% |
| Revenue Growth (this year): | -76.15% | Revenue Growth (next year): | -5.85% |
Latest Co-Diagnostics Inc. News
CODX Breaking Stock News: Dive into CODX Ticker-Specific Updates for Smart Investing
PR Newswire
a day ago
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast
PR Newswire
24 days ago
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States
PR Newswire
a month ago
Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21
PR Newswire
a month ago
Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform
CNW Group
2 months ago
Lotto 6/49 - $64 million up for grabs in the next draw!
Simply Wall St.
2 months ago
Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture
AFP
2 months ago
Seoul says it will resume loudspeaker propaganda against North
Simply Wall St.
2 months ago
It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend
Compare CODX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CODX Co-Diagnostics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.